Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite

被引:19
|
作者
Wang, Xiaopan [1 ]
Li, Li [2 ]
Huo, Wei [1 ]
Hou, Lulu [1 ]
Zhao, Zhiying [1 ]
Li, Weiguang [1 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 2, Dept Pharm, Nanjing 210028, Jiangsu, Peoples R China
来源
MATERIALS | 2013年 / 6卷 / 03期
基金
中国国家自然科学基金;
关键词
TanIIA; hydroxyapatite; solid dispersions; SALVIA-MILTIORRHIZA; COMPOSITE SCAFFOLDS; ENHANCEMENT; CRYPTOTANSHINONE; TEMPERATURE; SOLUBILITY; ABSORPTION; PHASE; ACID;
D O I
10.3390/ma6030805
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Solid dispersions of tanshinone IIA (TanIIA) using hydroxyapatite (HAp) as the dispersing carrier (TanIIA-HAp SDs) were prepared by the solvent evaporation method. The formed solid dispersions were characterized by scanning electron microscopy (SEM), differential scanning calorimetry analysis (DSC), X-ray powder diffraction (XRPD) and Fourier transforms infrared (FTIR) spectroscopy. The in vitro dissolution rate and the stability of TanIIA-HAp SDs were also evaluated. DSC and XRPD showed that TanIIA was changed from a crystalline to an amorphous form. FTIR suggested the presence of interactions between TanIIA and HAp in solid dispersions. The result of an in vitro dissolution study showed that the dissolution rate of TanIIA-HAp SDs was nearly 7.11-folds faster than free TanIIA. Data from stability studies for over one year of TanIIA-HAp SDs performed under room temperature revealed no significant differences in drug content and dissolution behavior. All these results indicated that HAp may be a promising carrier for improving the oral absorption of TanIIA.
引用
收藏
页码:805 / 816
页数:12
相关论文
共 50 条
  • [41] Solid dispersions with carbamazepine: optimization of formulation, characterization and examination of long-term stability
    Krstic, Marko
    Lukic, Igor
    Busatlic, Alma
    Lazarevic, Nenad
    Vasiljevic, Dragana
    HEMIJSKA INDUSTRIJA, 2018, 72 (04) : 191 - 204
  • [42] Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques
    Meng, Fan
    Gala, Urvi
    Chauhan, Harsh
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (09) : 1401 - 1415
  • [43] Solid-state characterization of nifedipine solid dispersions
    Vippagunta, SR
    Maul, KA
    Tallavajhala, S
    Grant, DJW
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 236 (1-2) : 111 - 123
  • [44] Preparation and characterization of pyrimethamine solid dispersions and an evaluation of the physical nature of pyrimethamine in solid dispersions
    Khatri, Pinak
    Shah, Mansi K.
    Patel, Niketkumar
    Jain, Shashank
    Vora, Namrata
    Lin, Senshang
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 45 : 110 - 123
  • [45] Cardiovascular actions and therapeutic potential of tanshinone IIA
    Gao, Si
    Liu, Zhiping
    Li, Hong
    Little, Peter J.
    Liu, Peiqing
    Xu, Suowen
    ATHEROSCLEROSIS, 2012, 220 (01) : 3 - 10
  • [46] Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro
    Hur, JM
    Shim, JS
    Jung, HJ
    Kwon, HJ
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2005, 37 (02): : 133 - 137
  • [47] Development of tanshinone IIA chitosan nanoparticles via chitosan solid dispersion for improving the therapeutical effects
    Luo, Chao
    Chen, Cong
    Zhang, Na
    Li, Jiani
    Liang, Yaru
    Wu, Weibin
    Yang, Kai
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 107
  • [48] Tanshinone IIA: A Promising Natural Cardioprotective Agent
    Shang, Qinghua
    Xu, Hao
    Huang, Li
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [49] Tanshinone Iia Inhibits Megakaryopoiesis in Immune Vasculitis
    Chen, Hui
    Zhou, Min
    Shu, Huiying
    Su, Weiqing
    Yang, Liuming
    Li, Liang
    Chong, Beng H.
    Yang, Mo
    BLOOD, 2021, 138
  • [50] Synthesis and vasodilative activity of tanshinone IIA derivatives
    Bi, Yue-Feng
    Xu, Hai-Wei
    Liu, Xiao-Qing
    Zhang, Xiao-Juan
    Wang, Zhen-Ji
    Liu, Hong-Min
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (16) : 4892 - 4894